Breast cancer: Carla Burni continues to follow daily treatment to avoid a recurrence

Breast cancer Carla Burni continues to follow daily treatment to

  • News
  • Published on
    Updated


    Reading 2 min.

    Five months after the announcement of her breast cancer, Carla Bruni spoke about the treatment that she continues to follow daily to prevent the appearance of new tumors.

    Like many personalities, Carla Bruni was not spared from cancer. She recently revealed details of the treatment she was undergoing.

    Breast cancer detected using a check-up mammogram

    On October 4, 2023, the former first lady and singer revealed that she had been diagnosed with breast cancer in 2019.

    I was lucky: my cancer was not yet aggressive“, she explains in a video on Instagram.

    A situation linked to the fact that she was able to benefit from mammography screening as it is offered to all. women aged 50 to 74 every two years.

    He didn’t have time to […] become aggressive“, she specifies, before adding that without this examination”she would no longer have a left breast today“.

    Daily treatment with hormone therapy

    To heal, the former top model underwent treatment with hormone therapy – which “aims to reduce or prevent the activity or production of a hormone that may stimulate the growth of a cancerous tumor“, underlines the National Cancer Institute.

    Hormone therapy that she still follows today, as she confided in the podcast Come on, I dare!” hosted by Elsa Wolinski.

    It’s about “an oncological treatment which is generally done for hormone-dependent cancers. There are many in the breast and prostate“, she explains, before continuing “C“is an active drug that shrinks tumors, makes cells disappear”.

    The star now seems to tolerate this treatment well (although she has complained in the past of pain and weight gain) which she has taken daily since her diagnosis and for a total duration of “five or seven years“. She is fully aware of the benefits linked to this treatment.

    An essential treatment to reduce the risk of recurrence

    Hundreds of thousands of women around the world take tamoxifen to prevent a recurrence after surgery for early-stage breast cancer. Tamoxifen is effective only in women with hormone-dependent tumors (whose growth is encouraged by hormones), and most of them take it immediately after their initial surgery or chemotherapy. Another class is also prescribed for this indication: anti-aromatases.

    This is also the treatment followed by Caroline Receveur, who is also battling breast cancer. In young women, it will induce early menopause which will be reversible when treatment is stopped. If you wish to become pregnant after treatment, the treatment must be stopped at least nine months before it begins.

    dts1